AGORA Progress Report Series is back!
AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
AGORA PRS | October 4th
Oncology Grand Rounds, Dr. Yohann Loriot | September 30th
Distinguished Lecture, Prof. Roger Stupp | October 5th
Lola and John Grace Distinguished Lecture in Cancer Research, Prof. Núria López-Bigas | October 5th
AGORA Decathlon Round 4: Canvas of Agora | October 12th
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress.
Montaldo E, Lusito E, Bianchessi V, (…), Ciceri F, Aiuti A, Ostuni R
Nature immunology – 2022 Sep 22
Patients’ experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey.
Arditi C, Eicher M, Colomer-Lahiguera S, (…), Duchosal M, Peters S, Peytremann-Bridevaux I
European journal of cancer care – 2022 Sep 21
Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity.
Chryplewicz A, Scotton J, Tichet M, (…), Joyce JA, Homicsko K, Hanahan D
Cancer Cell – 2022 Sep 15
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation.
Kandalaft LE, Dangaj Laniti D, Coukos G
Nature Reviews Cancer – 2022 Sep 15
Effectiveness of rib fixation compared to pain medication alone on pain control in patients with uncomplicated rib fractures: study protocol of a pragmatic multicenter randomized controlled trial-the PAROS study (Pain After Rib OSteosynthesis).
Perentes JY, Christodoulou M, Abdelnour-Berchtold E, (…), Triponez F, Terrier P, Bédat B
Trials – 2022 Sep 2